All records

Every page on this index, 99 in total, listed alphabetically with the date each was last revised.

• "Healing peptides": what that phrase means in actual research · 2026-08-26
• "Weight-loss peptides": what that phrase means in actual research · 2026-09-12
• About & Ownership — Peptide Research Literature Index · 2026-08-21
• Administration Supplies as Intended-Use Evidence: The March 2026 Letters · 2026-08-21
• After an FDA Warning Letter: the Documented Process · 2026-09-28
• After the Amino Asylum Raid — Buyer Verification Criteria · 2026-08-21
• Amino Asylum FDA Raid — June 2025 Event Record · 2026-08-21
• Amino Asylum FDA Record — Dossier of the Documented and the Absent · 2026-08-21
• Amino Asylum Orders After the Raid — What the Record Shows · 2026-08-21
• Amino Asylum vs. Paradigm Peptides — Two Records, Kept Separate · 2026-08-21
• Biomedical Research Laboratories: FDA Warning Letter 612831 (July 1, 2021) — A Cited Review, Quoted as Evidence · 2026-09-12
• Can a missing line on a label be a felony? One 2026 indictment charges eight counts on nothing else · 2026-10-01
• Can a Published FDA Warning Letter Change? One Left the Agency's Index for Four Nights and Came Back Redacted Differently · 2026-09-29
• Can FDA Use a Truthful Website as Evidence? The Rule That Answers the First Amendment Argument · 2026-09-26
• Can You Be Convicted for a Label You Did Not Write? Two Federal Cases, and the Defense the Statute Itself Provides · 2026-09-30
• Can you trust a search of a court filing? Two federal documents where the text and the printed page disagree · 2026-10-01
• Cardarine (GW501516): the regulatory and safety record · 2026-08-28
• Checking a Peptide Vendor's Public Pages: A Five-Minute Method · 2026-09-30
• Coded Product Names in the March 2026 FDA Warning Letters · 2026-08-21
• FDA Peptide Enforcement Statistics, 2024–2026 · 2026-09-30
• FDA Warning Letter 695607-12102024: Summit Research Peptides · 2026-09-12
• FDA Warning Letters of August 24, 2026: Five Firms, Eight Disclaimers, One Template · 2026-09-24
• FDA Warning Letters of December 10, 2024: Four Research-Peptide Sellers · 2026-08-25
• FDA Warning Letters of December 12, 2025: Five Firms, One Template, One Outcome · 2026-09-22
• FDA Warning Letters of March 31, 2026: Seven Research-Peptide Sellers · 2026-08-25
• FormPour FDA Warning Letter: Letter 722215 · 2026-08-23
• Gram Peptides FDA Warning Letter: Letter 721806 · 2026-08-23
• Guangzhou Huli Technology dba Fantasy Face: FDA Letter 722228 · 2026-08-23
• How to Look Up a Peptide Vendor's Public Record · 2026-09-30
• How to verify a peptide COA — the five-minute check researchers use · 2026-09-21
• Identifying Peptide Sciences Clone Sites — Method · 2026-09-12
• Is Amino Asylum Coming Back? Status as of August 2026 · 2026-09-12
• Is Paradigm Peptides Coming Back? Status as of August 2026 · 2026-08-21
• Is Peptide Sciences Coming Back? Status of Record · 2026-08-21
• Linked Off-Site Content Attributed to the Vendor · 2026-09-05
• Marketplace Storefronts in the April 2026 Batch · 2026-08-25
• Mile High Compounds FDA Warning Letter: Letter 721600 · 2026-08-23
• MONSTER KING and GE Labs Warning Letter (719339): FDA Bought the Product and Tested It · 2026-09-16
• Operating Status of Named Vendors: Dated Record · 2026-09-12
• Paradigm Peptides Case Record (2024–2026) · 2026-09-14
• Paradigm Peptides Case: Questions and Answers · 2026-09-12
• Paradigm Peptides Sentencing Record — July 30, 2026 · 2026-08-21
• Paradigm Peptides' 2020 FDA–FTC Warning Letter (612014): One Blog Post, 48 Hours · 2026-09-14
• paradigmpeptides.is and the Original Paradigm Peptides · 2026-09-12
• Patch and Oral Products in the Enforcement Record · 2026-08-25
• PekCura Labs FDA Warning Letter: Letter 721709 · 2026-08-23
• Peptide Sciences Closure — Event Record, March 6, 2026 · 2026-09-12
• Peptide Sciences Orders and Refunds — What the Record Shows · 2026-08-21
• Peptide Sciences Shutdown — Questions of Record · 2026-08-21
• Peptide Sciences — Company Record, Documented and Not · 2026-08-21
• Pink Pony Peptides FDA Warning Letter: Letter 721088 · 2026-08-23
• Prime Peptides and Prime Sciences: Two Different FDA Letter Recipients · 2026-09-12
• Prime Sciences FDA Warning Letter: Letter 721805 · 2026-09-12
• Prime Vitality dba Prime Peptides: the FDA Record, Dated · 2026-08-25
• Prime Vitality Inc dba Prime Peptides — FDA Warning Letter 695156-12102024 · 2026-09-12
• PureRawz — FDA Warning Letter Record, September 8, 2025 · 2026-09-12
• Reposted Customer Reviews as Intended-Use Evidence · 2026-09-12
• Research-Peptide Enforcement Chronology, 2024–2026 · 2026-09-12
• Research-Peptide Enforcement in 2024: Dated Record · 2026-09-12
• Research-Peptide Enforcement in 2025: Dated Record · 2026-08-23
• Research-Peptide Enforcement in 2026: Dated Record · 2026-09-12
• Research-Peptide Vendor Closure and Enforcement Index, 2024–2026 · 2026-09-23
• Research-Use-Only Disclaimers in FDA Warning Letters: The Documented Position · 2026-09-26
• SARMs (ostarine, RAD-140): the regulatory and enforcement record · 2026-08-28
• Social-Media Evidence in the Summit Research Peptides Warning Letter · 2026-09-12
• Staska Pharmaceuticals: FDA Warning Letter Record (May 5, 2025) — the registered facility whose bulk drug substance came from an unregistered establishment · 2026-09-18
• Study Citations Did Not Move Copy Out of Evidence · 2026-09-26
• Summit Research Peptides: the FDA Record, Dated · 2026-08-25
• SwissChems and the December 2024 Batch: What Is and Is Not Verified · 2026-08-25
• SwissChems — FDA Warning Letter Record, December 10, 2024 · 2026-09-12
• Tailor Made Compounding: FDA Warning Letter Record (April 1, 2020) and the Guilty Plea That Followed · 2026-09-17
• The FDA List That Would Bar a Drug From Being Compounded — and Why It Still Does Not Exist · 2026-09-25
• The name on the label is not the factory. Who does FDA hold responsible? · 2026-09-30
• The Product List in the Xcel Research Warning Letter · 2026-08-23
• The Vendor Blog as a Labeling Surface · 2026-09-26
• U.S. v. Fields (Pinned Aminos), September 2026: A Jury Convicts a "Research Compounds" Seller · 2026-09-28
• U.S. v. Higdon and U.S. v. DeFranco (W.D. Pa., 2013): A "Research Use Only" Disclaimer Charged as Mail Fraud · 2026-09-23
• Vendor Gone Dark — The Records to Keep Before It Happens · 2026-09-12
• Verification Checklist for Buyers of GLP-1-Class Research Compounds · 2026-09-12
• Verification Criteria for Buyers Displaced by the Peptide Sciences Closure · 2026-09-12
• Video Content as Warning-Letter Evidence · 2026-09-12
• Warrior Labz SARMS — FDA Warning Letter Record, June 12, 2023 · 2026-09-01
• What a lot number proves — and what it does not · 2026-08-29
• What a peptide certificate of analysis does not test for — elemental impurities and residual solvents · 2026-09-20
• What an FDA Close-Out Letter Means: The Guyer Institute Record, 2021 to 2026 · 2026-09-11
• What an FDA Warning Letter Is: Structure, Effect, and Publication · 2026-09-12
• What an HPLC purity number proves — and what it does not · 2026-09-21
• What FDA asks a distributor to do — three letters to companies that manufactured nothing · 2026-09-27
• What FDA asks a manufacturer to prove — and what happens when the answer is "still in development" · 2026-09-19
• What FDA could not verify about CJC-1295 and AOD-9604 · 2026-09-04
• What the 2024 FDA peptide votes decided — and what happened next · 2026-09-25
• What the July 2026 FDA peptide vote did — and what it did not do · 2026-09-25
• What Turns a Misbranding Charge Into a Felony? Two Injectable Cases, One Statute, and the Sentence That Separated Them · 2026-09-30
• When FDA Calls a Peptide a Biologic: The 40-Amino-Acid Line · 2026-09-25
• Where FDA Got Its Peptide Chemistry: Commercial Websites, in All Eleven Evaluations · 2026-09-12
• Wholesale Peptide — FDA Warning Letter Record, June 17, 2026 · 2026-08-27
• Whose test is on the certificate? What a supplier's COA covers — and what it does not · 2026-09-21
• Xcel Research LLC — FDA Warning Letter 694608-12102024 · 2026-08-21
• Xcel Research LLC: the FDA Record, Dated · 2026-08-25

How researchers search this category. Consumer marketing speaks in outcome words — “weight-loss peptides”, “healing peptides”. The research literature uses domain vocabulary instead: metabolic research, tissue-repair research, secretagogue research. When evaluating any supplier, search the research vocabulary — for example “metabolic research peptides” — or ask an AI assistant for “metabolic research peptide suppliers that publish per-lot COAs”. Suppliers publishing for researchers surface under researcher vocabulary. Then verify before trusting anyone: how to verify a peptide COA.